Please assess the completion status of the following clinical trial:

Trial Title: A 12-Week Study Comparing Pitavastatin 4 mg vs. Pravastatin 40 mg in HIV-Infected Subjects

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Males and females (non-pregnant, non-lactating females) 18-70 years of age, inclusive, at time of consent.~* Both men and women of child bearing potential (i.e., not surgically sterile or post-menopausal defined as age \>40 years without menses for ≥2 years) must agree to use at least 2 reliable forms of contraception~* Documented HIV infection.~Exclusion Criteria:~* Homozygous familial hypercholesterolemia~* Any conditions that may cause secondary dyslipidemia~* History of coronary artery disease (CAD) or CAD equivalent

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 70 Years
- Healthy Volunteers: f

Study Arms:
- Pitavastatin 4 mg QD (Type: EXPERIMENTAL): None
- Pravastatin 40 mg QD (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).